ADAPTABLE Study

05/15/2021

Presented at , The American College of Cardiology and published in the New England Journal of Medicine, Schulyer Jones, MD, the principal investigator of the ADAPTABLE study,
shares results. DCRI Watch:

05/02/2019

Doctors rely on results from clinical research studies to know what treatment is best their patients. Results from the PCORI-funded will inform clinicians on what dose is best for people living with to reduce the risk of a future heart attack or stroke while minimizing side effects. Learn more from this Association of American Medical Colleges article: http://bit.ly/2J9t2LY

12/07/2018

Today we reached 12 thousand participants enrolled! Congratulations to the team on your continued success in transforming & understanding what is the best dose of aspirin for people with .

06/05/2018

Participants share why they joined the ADAPTABLE Study on a page dedicated to their voice: bit.ly/ADPcomm

The ADAPTABLE Study is building a community where participants, researchers, and clinicians actively engage one another and partner together to improve cardiovascular health. Participants receive a quarterly newsletter with updates about the study and insights into research team members. There is al...

05/23/2018

Learn more about the ADAPTABLE Study on Pitt Plus Me.

Have you been diagnosed with ? If so, you may be able to participate in a research study to help find out which dose of aspirin is best at preventing attacks and in people with heart disease. Visit https://goo.gl/H21kKX for details.

04/11/2018

The ADAPTABLE Study empowers patients to be part of the research process. We invite you to get to know Linda and her fellow patient partners: bit.ly/mtadaptors

03/28/2018

Patient partners bring a wealth of knowledge and experience to clinical research. Learn how ADAPTABLE patient stakeholders are part of the research process: bit.ly/ADPTEACC

03/23/2018

What can we learn when we partner with patients in clinical trials? Dr. Dan Munoz explains how patients challege and help clinicians and researchers. bit.ly/ADPTEACC CardioSmart

Jacqueline Alikhaani, a rare disease heart patient and partner on the ADAPTABLE Study, is passionate about the value and impact of novel clinical research studies. Alikhaani is especially passionate about studies that leverage electronic health records and common data resources, and includes patient...

03/22/2018

Interested in learning more about patient-researcher partnerships? The ADAPTABLE Study team shares their experiences at the CardioSmart Patient Engagement Pavilion, ACC 18

Jacqueline Alikhaani, a rare disease heart patient and partner on the ADAPTABLE Study, is passionate about the value and impact of novel clinical research studies. Alikhaani is especially passionate about studies that leverage electronic health records and common data resources, and includes patient...

03/21/2018

In ADAPTABLE, we are grateful for the opportunity to receive insights from study participants and to share their voice. We invite you to read respones from participants on why they joined ADAPTABLE: theaspirinstudy.org/participantvoice/

03/13/2018

Patient partners, clinicians, and researchers discuss leveraging patient engagement strategies in the ADAPTABLE Study. Check out these pictures from the CardioSmart Patient Engagement Pavilion at the American College of Cardiology (ACC) annual conference in Orlando, Florida.

02/23/2018

Have you wondered how patients can work with researchers in clinical trials to improve health? Bill Larsen, a patient partner in ADAPTABLE, provides insights on his role and experiences working alongside the study team. Learn more: bit.ly/larsenprt